COEP
Price
$12.66
Change
-$0.66 (-4.95%)
Updated
Aug 28 closing price
Capitalization
61.03M
SCNI
Price
$1.46
Change
-$0.02 (-1.35%)
Updated
Aug 28 closing price
Capitalization
1.46M
Interact to see
Advertisement

COEP vs SCNI

Header iconCOEP vs SCNI Comparison
Open Charts COEP vs SCNIBanner chart's image
Coeptis Therapeutics Holdings
Price$12.66
Change-$0.66 (-4.95%)
Volume$33.57K
Capitalization61.03M
Scinai Immunotherapeutics
Price$1.46
Change-$0.02 (-1.35%)
Volume$62.17K
Capitalization1.46M
COEP vs SCNI Comparison Chart in %
Loading...
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COEP vs. SCNI commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COEP is a Buy and SCNI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (COEP: $12.66 vs. SCNI: $1.46)
Brand notoriety: COEP and SCNI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COEP: 66% vs. SCNI: 4%
Market capitalization -- COEP: $61.03M vs. SCNI: $1.46M
COEP [@Biotechnology] is valued at $61.03M. SCNI’s [@Biotechnology] market capitalization is $1.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COEP’s FA Score shows that 0 FA rating(s) are green whileSCNI’s FA Score has 1 green FA rating(s).

  • COEP’s FA Score: 0 green, 5 red.
  • SCNI’s FA Score: 1 green, 4 red.
According to our system of comparison, both COEP and SCNI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COEP’s TA Score shows that 3 TA indicator(s) are bullish while SCNI’s TA Score has 5 bullish TA indicator(s).

  • COEP’s TA Score: 3 bullish, 5 bearish.
  • SCNI’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SCNI is a better buy in the short-term than COEP.

Price Growth

COEP (@Biotechnology) experienced а -5.73% price change this week, while SCNI (@Biotechnology) price change was -15.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COEP($61M) has a higher market cap than SCNI($1.46M). COEP YTD gains are higher at: 130.182 vs. SCNI (-56.353). SCNI has higher annual earnings (EBITDA): 7.8M vs. COEP (-11.18M). COEP has more cash in the bank: 2.99M vs. SCNI (1.03M). SCNI has less debt than COEP: SCNI (1.23M) vs COEP (1.33M). SCNI has higher revenues than COEP: SCNI (452K) vs COEP (264K).
COEPSCNICOEP / SCNI
Capitalization61M1.46M4,178%
EBITDA-11.18M7.8M-143%
Gain YTD130.182-56.353-231%
P/E RatioN/A1.19-
Revenue264K452K58%
Total Cash2.99M1.03M289%
Total Debt1.33M1.23M109%
FUNDAMENTALS RATINGS
COEP vs SCNI: Fundamental Ratings
COEP
SCNI
OUTLOOK RATING
1..100
123
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3795
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7511

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCNI's Valuation (12) in the Pharmaceuticals Major industry is somewhat better than the same rating for COEP (69) in the null industry. This means that SCNI’s stock grew somewhat faster than COEP’s over the last 12 months.

COEP's Profit vs Risk Rating (94) in the null industry is in the same range as SCNI (100) in the Pharmaceuticals Major industry. This means that COEP’s stock grew similarly to SCNI’s over the last 12 months.

COEP's SMR Rating (100) in the null industry is in the same range as SCNI (100) in the Pharmaceuticals Major industry. This means that COEP’s stock grew similarly to SCNI’s over the last 12 months.

COEP's Price Growth Rating (37) in the null industry is somewhat better than the same rating for SCNI (95) in the Pharmaceuticals Major industry. This means that COEP’s stock grew somewhat faster than SCNI’s over the last 12 months.

COEP's P/E Growth Rating (100) in the null industry is in the same range as SCNI (100) in the Pharmaceuticals Major industry. This means that COEP’s stock grew similarly to SCNI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COEPSCNI
RSI
ODDS (%)
Bearish Trend 1 day ago
51%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
46%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
52%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
42%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
63%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 29 days ago
77%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
41%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
22%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANGO10.130.12
+1.20%
AngioDynamics
AMR145.880.26
+0.18%
Alpha Metallurgical Resources
PCTTU17.80N/A
N/A
PureCycle Technologies
ALGN141.13-0.85
-0.60%
Align Technology
EQ1.82-0.09
-4.71%
Equillium

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with TAOX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
-1.35%
TAOX - SCNI
73%
Closely correlated
-5.42%
SYRE - SCNI
43%
Loosely correlated
-2.45%
MBIO - SCNI
37%
Loosely correlated
+0.98%
BIVI - SCNI
34%
Loosely correlated
-8.64%
VANI - SCNI
32%
Poorly correlated
-3.28%
More